The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

The Globe and Mail has
updated our Stock Quote Pages
You are about to experience the newly designed Stock Quote Pages format. With the new layout, you'll enjoy a more in-depth look at the companies you're following and pages that are easier to navigate. This Editors' blog post explains why we've made these changes.

 

Johnson & Johnson

NYSE: JNJ
Last

(U.S.) $100.34

Today's change+0.20 +0.20%
Updated March 27 4:01 PM EDT. Delayed by at least 15 minutes.
 

Johnson & Johnson

NYSE: JNJ
Last

(U.S.) $100.34

Today's change+0.20 +0.20%
Updated March 27 4:01 PM EDT. Delayed by at least 15 minutes.

Johnson & Johnson up (U.S.)$0.20

Johnson & Johnson closed up Friday by (U.S.)$0.20 or 0.20% to (U.S.)$100.34. Over the last five days, shares have lost 2.01% and are down 4.05% for the last year to date. This security has underperformed the S&P 500 by 8.32% during the last year.

Key company metrics

  • Open(U.S.) $100.28
  • Previous close(U.S.) $100.14
  • High(U.S.) $100.95
  • Low(U.S.) $100.15
  • Bid / Ask-- / --
  • YTD % change-4.05%
  • Volume5,847,382
  • Average volume (10-day)8,396,788
  • Average volume (1-month)8,391,183
  • Average volume (3-month)9,107,125
  • 52-week range(U.S.) $95.10 to (U.S.) $109.49
  • Beta0.58
  • Trailing P/E17.60×
  • P/E 1 year forward16.26×
  • Forward PEG2.73×
  • Indicated annual dividend(U.S.) $2.80
  • Dividend yield2.79%
  • Trailing EPS(U.S.) $5.70
Updated March 27 4:01 PM EDT. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+21.96%

Based on its net profit margin of 21.96%, Johnson & Johnson is less effective than other companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX0.39%Sector:HealthcareIndustry:Pharmaceuticals - Diversified
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q4/2014Q3/2014Q2/2014Q1/2014
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedDec 28, 201412/28/2014Sep 28, 201409/28/2014Jun 29, 201406/29/2014Mar 30, 201403/30/2014
Revenue18,25418,46719,49518,115
Total other revenue--------
Total revenue18,25418,46719,49518,115
Gross profit12,40113,06813,45612,660
Total cost of revenue5,8535,3996,0395,455
Total operating expense15,55111,65713,86912,691
Selling / general / administrative5,8225,4685,4815,183
Research & development2,6352,0232,0051,831
Depreciation / amortization--------
Interest expense (income), net operating139130128136
Unusual expense (income)1560418
Other operating expenses, total1,016-1,34717195
Operating income2,7036,8105,6265,424
Interest income (expense), net non-operating--------
Gain (loss) on sale of assets--------
Other--------
Income before tax2,7036,8105,6265,424
Income after tax2,5214,7494,3264,727
Income tax, total1822,0611,300697
Net income2,5214,7494,3264,727
Total adjustments to net income--------
Net income before extra. items2,5214,7494,3264,727
Minority interest0------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items2,5214,7494,3264,727
Inc. avail. to common incl. extra. items2,5214,7494,3264,727
Diluted net income2,5214,7494,3264,727
Dilution adjustment0--0--
Diluted weighted average shares2,8422,8642,8742,875
Diluted EPS excluding extraordinary itemsvalue per share0.891.661.511.64
Dividends per sharevalue per share0.700.700.700.66
Diluted normalized EPSvalue per share0.292.001.651.69